生物活性 靶点 体外研究 体内研究 4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid 试剂级价格
ChemicalBook  CAS数据库列表  4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid

4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid

4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid,215030-90-3,结构式
4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid
  • CAS号:215030-90-3
  • 英文名:4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid
  • 中文名:4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid
  • CBNumber:CB22518846
  • 分子式:C29H24O2
  • 分子量:404.5
  • MOL File:215030-90-3.mol
4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid化学性质
  • 沸点 :605.4±55.0 °C(Predicted)
  • 密度 :1.21±0.1 g/cm3(Predicted)
  • 储存条件 :2-8°C
  • 溶解度 :DMSO: ≥20mg/mL
  • 酸度系数(pKa) :4.27±0.10(Predicted)
  • 形态 :powder
  • 颜色 :light yellow to yellow
安全信息
  • WGK Germany :2

4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid性质、用途与生产工艺

  • 生物活性 BMS493 是一种反向泛视黄酸受体 (RARs) 激动剂。BMS493 增加了 RARs 与核共抑制因子的相互作用,还可阻止视黄酸诱导的分化。
  • 靶点

    RAR

  • 体外研究

    BMS493 (100 nM; 6 days; ALDHhi UCB cells) treatment shows a twofold increase in the number of ALDHhi cells available for transplantation compared with untreated controls. Newly expanded ALDHhi cells shows increased numbers of CD34 and CD133-positive cells, as well as a reduction in CD38 expression, a marker of hematopoietic cell differentiation.

    Cell Viability Assay

    Cell Line: ALDHhi UCB cells
    Concentration: 100 nM
    Incubation Time: 6 days
    Result: Showed a twofold increase in the number of ALDHhi cells available for transplantation compared with untreated controls.
  • 体内研究

    Intrapancreatic transplantation of cell progeny after expansion of ALDHhi cells with or without BMS493 shows no reduction of hyperglycemia in Streptozotocin-treated NOD/SCID mice. Thus, Umbilical cord blood (UCB)-derived ALDHhi cells effectively lost islet regenerative capacity during ex vivo expansion.

4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid上下游产品信息
上游原料
下游产品
4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid 试剂级价格
  • 更新日期:2025/02/08
  • 产品编号:HY-108529
  • 产品名称:BMS493
  • CAS编号:215030-90-3
  • 包装:1 mg
  • 价格:363元
  • 更新日期:2025/02/08
  • 产品编号:HY-108529
  • 产品名称:4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid BMS493
  • CAS编号:215030-90-3
  • 包装:5mg
  • 价格:800元
4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid生产厂家
  • 公司名称:TOCRIS-US
  • 联系电话:--
  • 电子邮件:customerservice@tocris.co.uk
  • 国家:英国
  • 产品数:5726
  • 优势度:77
215030-90-3, 4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoicacid相关搜索: